Document is current
Any future updates will be listed below
-
Authors
Koufakis, Theocharis https://orcid.org/0000-0002-5853-1352
Tentolouris, Anastasios
Karakasis, Paschalis
Popovic, Djordje S.
Patoulias, Dimitrios
- License Information
-
More Information
Article History
Received: 30 July 2026
Accepted: 5 September 2026
First Online: 28 September 2026
Declarations
Conflict of Interest: Theocharis Koufakis has received honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Menarini, Sanofi, Roche Diagnostics, ELPEN, Krka, and Novo Nordisk; honoraria for advisory boards from Novo Nordisk and Boehringer Ingelheim; and has participated in sponsored studies by Eli Lilly, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk. Theocharis Koufakis is an Editorial Board member of Advances in Therapy . Theocharis Koufakis was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Djordje S. Popovic declares relationships with Abbott, Alkaloid, AstraZeneca, Boehringer Ingelheim, Berlin-Chemie, Eli Lilly, Galenika, Krka, Merck, Novo Nordisk, PharmaSwiss, Sanofi-Aventis, Servier, Viatris, and Wörwag Pharma. Dimitrios Patoulias is an Editorial Board member of Advances in Therapy . Dimitrios Patoulias was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Anastasios Tentolouris and Paschalis Karakasis declare that they have no competing interests.
Ethical Approval: This article is based on previously published studies and does not contain any new studies with human participants or animals performed by any of the authors. Ethical approval was therefore not required.
